Top Business Stories from the U.S.
Updated: 7 hours 58 min ago
The stock market has been able to bounce back from negative headline and set new highs. But, some stocks have fared better.
The earthquake that struck California may cause more $1 billion in losses and the majority of residents will be on their own.
Facebook made the announcement via a blog post that it will be cracking down on click-bait on news feeds, NBCNews reports.
Shares of Tim Hortons surged on news that Burger King may buy it. The Canadian company's stock may yet have room to run.
Sony's PlayStation was the target of a cyber-attack over the weekend.
Here's why 40 is the key number for the GOP to regain control of the Senate in this fall's midterm elections, says ex-Treasury official Stephen Myrow.
The secret attacks were against Islamist militias in Libya, U.S. officials say. The NYT reports.
When it comes to fast food, McDonald’s is king. But on Wall Street, the Golden Arches are getting a run for their money. USAToday reports.
Burger King's move to buy Tim Hortons would give it a major presence up north. It would also save it a whopper of a tax bill.
The possibility of a new iPhone with a larger screen could be a game changer for Apple's stock, say some investors.
The S&P 500's push through 2,000 signals further gains ahead as the market rides positive momentum.
U.S. Trust CIO Chris Hyzy says that the stock market is just five years into a 20-year bull market.
Detroit expects the refinancing will result in savings projected at about $241 million over 26 years.
Comic books are a vital part of the collectibles market and can be profitable for collectors holding highly sought items.
Tuesday talks may look like a move toward a solution to the war in Ukraine, but experts aren't hopeful.
A female soldier shot herself at a Virginia Army base, but didn't wound any others, the Army says.
Apple revealed on Friday that it will be replacing batteries in a small percentage of iPhone 5 devices.
The S&P 500 index's crossing 2,000 for the first time is just an "item of note," says veteran trader Art Cashin.
Roche's deal for InterMune returns to the traditional model of big pharma buying smaller biotech.
Earthquake aside, I noted some interesting trends and observations on my visit to the San Francisco area.